• ABOUT
  • ADVERTISE
  • PRIVACY POLICY
  • TERMS OF USE
  • CAREERS
  • CONTACT
Monday, January 25, 2021
Subscribe to Newsletter
No Result
View All Result
Whistleblower Network News
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
Whistleblower Network News
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
No Result
View All Result
Whistleblower Network News
No Result
View All Result
Home News False Claims-Qui Tam

Whistleblower in Tamiflu Case Alleges Pharmaceutical Company Fooled CDC into $1.4 Billion Contract

Peter BriccettibyPeter Briccetti
July 8, 2020
in False Claims-Qui Tam
Reading Time: 2min read
0
Whistleblower in Tamiflu Case Alleges Pharmaceutical Company Fooled CDC into $1.4 Billion Contract
Share on TwitterShare on FacebookShare on LinkedInEmail

The pharmaceutical company Hoffmann-La Roche allegedly defrauded the federal government out of $1.4 billion by falsely representing claims of the drug Tamiflu’s effectiveness and potential in a pandemic, according to a False Claims Act whistleblower lawsuit unsealed in September of 2019.

Responding to La Roche’s motion to dismiss the lawsuit, the whistleblower, Dr. Thomas Jefferson, alleged that the company knew Tamiflu didn’t reduce the contagiousness of influenza or prevent people from contracting it. Studies show that Tamiflu reduces the duration of symptoms by half a day on average but does not stop the flu from spreading to others during that period. This effect may increase the overall contagiousness of influenza as asymptomatic people may still be contagious.

The lawsuit alleges that La Roche fooled the government into buying tens of millions of courses of Tamiflu by misrepresenting the data on Tamiflu’s effectiveness to the federal government and the public. La Roche allegedly created a campaign to produce and publish articles in medical journals showing that Tamiflu would be useful in a pandemic. These studies convinced the government and the CDC to grant La Roche a contract to supply Tamiflu to the National Stockpile. Under the False Claims Act, a company that defrauds the government must pay triple the amount of money misappropriated or defrauded, not including individual fees and fines for each proven infraction. If found guilty, La Roche could have to pay upwards of $4.5 billion.

False Claims Act whistleblowers, or qui tam relators such as Dr. Jefferson, can earn rewards of 15 to 30% of the funds recovered by the federal government. Cases like this one are perfect examples of how effective the False Claims Act is at uncovering fraud and deception against the federal government and taxpayers.

Read Is Tamiflu Part Of A $1.5 Billion Fraud?

Protect Yourself: Purchase the New Whistleblower Handbook Protect Yourself: Purchase the New Whistleblower Handbook Protect Yourself: Purchase the New Whistleblower Handbook
Tags: Qui Tamqui tam lawsuit
Peter Briccetti

Peter Briccetti

Peter Briccetti is a contributing editor with Whistleblower Network News. He writes about breaking whistleblower news, and False Claims Act whistleblowers, FCPA whistleblowers, and tax fraud whistleblowers. Peter is a graduate of Hamilton College with a degree in History and an interest in politics and anti-corruption law. At Hamilton, he wrote for the Hamilton College Spectator as an editor and contributor.

Write a Letter to The Editor.

Most Popular

Grenfell Tower Fire Whistleblowers Caught in Legal Limbo

Yellen Dodges Senate Whistleblower Question

Who Is Rebekah Jones? Profile on Florida COVID-19 Data Scientist

IUCN Motions Essential In Guiding New International Whistleblower Law, Environmental Whistleblower Policy Expert Explains

Allison Lee Appointed Acting Chair of SEC

Whistleblower Complaint Leads to SEC Investigation of Exxon

Whistleblower Poll

Increased Whistleblower Protections
Legislation

Candidate’s Position on Increased Whistleblower Protections Influences 44% of Likely Voters

byAna Popovich
October 6, 2020
0

Protect Yourself: Buy the New Whistleblower Handbook Protect Yourself: Buy the New Whistleblower Handbook Protect Yourself: Buy the New Whistleblower Handbook

STAY INFORMED. Sign up for daily whistleblower email and social notifications from the Whistleblower Network News.

  • This field is for validation purposes and should be left unchanged.

Qui Tam

  • Dodd-Frank
  • IRS & Tax
  • SEC
  • Foreign Corruption
  • False Claims-Qui Tam

Retaliation

  • OSHA
  • Sarbanes-Oxley

Government

  • Government
  • Intelligence
  • Legislation
  • Veterans

Features

  • Whistleblower of the Week
  • Editorial
  • Features
  • Interviews
  • Opinion

Resources

  • FAQs
  • National Whistleblower Day
  • National Whistleblower Center
  • Whistleblower Handbook
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article
  • ABOUT
  • ADVERTISE
  • PRIVACY POLICY
  • TERMS OF USE
  • CAREERS
  • CONTACT

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the lawyer or law firm publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

No Result
View All Result
  • Home
  • News
    • Corporate
    • Dodd-Frank
    • False Claims-Qui Tam
    • Foreign Corruption
    • Government
    • Intelligence
    • IRS & Tax
    • Legislation
    • OSHA
    • Sarbanes-Oxley
    • SEC
  • Editorial
  • Opinion
  • Whistleblower of the Week
  • Login

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

Welcome Back!

Sign In with Facebook
Sign In with Google
OR

Login to your account below

Forgotten Password?

Create New Account!

Sign Up with Facebook
Sign Up with Google
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Go to mobile version